Results 171 to 180 of about 7,998,845 (308)
Living with a rare disease: Why lived experience must shape research. [PDF]
Whyatt G, Whitehouse J.
europepmc +1 more source
ABSTRACT Background Factors associated with relapse course and disability in myelin oligodendrocyte glycoprotein antibody‐associated disease (MOGAD) remain incompletely understood. Objectives To identify clinical and modifiable factors associated with relapse and disability in MOGAD. Methods In this ambispective multicentre cohort study using data from
Yingtao Wang +23 more
wiley +1 more source
P084: High efficacy on low-dose empagliflozin efficacy in glycogen storage disease-1b sibling pair
Jennifer Russell +5 more
doaj +1 more source
Bi‐ and Mono‐Allelic RFC1 Expansion in a North American Cohort With Idiopathic Axonal Neuropathy
ABSTRACT Objective RFC1 biallelic repeat expansion is increasingly recognized as a cause of chronic idiopathic axonal polyneuropathy (CIAP), but it remains challenging to know who to test. This study aims to determine the prevalence of biallelic and monoallelic RFC1 expansions and their corresponding neuropathy phenotypes in CIAP patients and identify ...
Amro M. Stino +25 more
wiley +1 more source
The final programme for the one-day conference “A common international standard for rare materials cataloguing? Why? And how?” at the Biblioteca Nacional de Portugal (Lisbon) has been released.
IFLA Rare Books & Special Collections Section
core
Strengthening Rare Disease Data Readiness: a semantic approach to cross-registry interoperability. [PDF]
Hentrich CM +10 more
europepmc +1 more source
Digital Cognitive Testing in Mitochondrial Disease: Validity and Challenges for Clinical Trial Use
ABSTRACT Background Primary mitochondrial disease is a group of genetic disorders caused by pathogenic variants in nuclear or mitochondrial DNA, often resulting in progressive neurodegeneration and cognitive decline. Current management is primarily supportive, though recent research offers hope for disease‐modifying treatments in the future.
Oksana Pogoryelova +9 more
wiley +1 more source
Developing a rare disease registry for inherited metabolic disorders in Pakistan. [PDF]
Jafri L +6 more
europepmc +1 more source
ABSTRACT Objective Building on our prior Behavioral Risk Factor Surveillance System analysis identifying adults aged 18–39 as the primary driver of the national increase in self‐reported cognitive disability, we examined factors associated with this rise using 2013–2024 U.S. BRFSS data. Methods We analyzed U.S.
Adam de Havenon +9 more
wiley +1 more source
Reprogramming translation for rare disease therapy: challenges posed by large genes. [PDF]
Pattnaik BR, Sahel JA.
europepmc +1 more source

